Association of Microcirculation Parameters with Mortality in Patients with Coronary Artery Disease Combined with COVID-19

DOI: https://doi.org/10.30702/ujcvs/24.32(04)/NM068-6777
Keywords: mortality risk score, predictors of mortality, microvascular blood flow, laser Doppler flowmetry, digital capillaroscopy, transcranial Doppler monitoring, microembolic signals

Abstract

The aim. To investigate the association of microcirculation parameters with deaths in patients with coronary artery disease and COVID-19.

Materials and methods. From January 2020 to December 2022, 79 patients with coronary artery disease (CAD) without COVID-19, 127 patients with CAD and COVID-19, and 180 patients with COVID-19 without CAD were examined at the clinical sites of the Bogomolets National Medical University. The control group consisted of 37 healthy volunteers. Digital capillaroscopy (DC) was performed to assess the caliber and length of arterial and venous parts of the capillaries, as well as velocity of red blood cells therein. Laser Doppler flowmetry (LDF) was used to measure the microcirculation index and capillary blood flow reserve. Wavelet analysis of the basal LDF signal was also performed and the maximum amplitudes of fluxmotions were measured: endothelial, neurogenic, myogenic, respiratory, and cardiac. All the patients underwent transcranial Doppler monitoring to detect microembolic signals.

Results. The greatest damage to the microcirculatory bed was observed in patients with CAD and COVID-19. The risk of death was 6.3% in patients with CAD, 22% in those with CAD combined with COVID-19, and 6.1% in patients with COVID-19. According to the LDF, the risk of death increases at certain values of flux amplitudes, and according to the DC, with a decrease in capillary caliber and blood flow velocity. The index of mortality risk assessment was proposed with the consideration of amplitudes of neurogenic fluxmodes, caliber of venous part of the capillaries, velocity of red blood cells in arterial part of the capillaries, microcirculation index and presence of CAD and/or COVID-19.

Conclusions. In patients with CAD and COVID-19, deterioration of microcirculation regulation, decreased erythrocyte velocity and increased microembolic signals were found. It is proposed to use the index for assessing the risk of mortality in patients with COVID-19.

References

  1. Kozłowski P, Leszczyńska A, Ciepiela O. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review. Am J Med Open. 2024;11:100068. https://doi.org/10.1016/j.ajmo.2024.100068
  2. He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020;92(7):719-725. https://doi.org/10.1002/jmv.25766
  3. Lakhani HV, Pillai SS, Zehra M, Sharma I, Sodhi K. Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population. Int J Environ Res Public Health. 2020;17(12):4279. https://doi.org/10.3390/ijerph17124279
  4. Tylishchak ZR. [Peculiarities of endothelial dysfunction and capillary blood flow in patients with covid-19 coronavirus disease and concomitant type 2 diabetes mellitus]. Bukovinian Medical Herald. 2023;27(1):37-41. Ukrainian. https://doi.org/10.24061/2413-0737.27.1.105.2023.7
  5. Doncheva-Dilova J, Boyadzhieva Vl, Stoilov N, Lambova S. Capillaroscopy in COVID-19. Rheumatology (Bulgaria). 2023;31(2):41-57. https://doi.org/10.35465/31.2.2023.pp41-57
  6. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139-e596. https://doi.org/10.1161/CIR.0000000000000757
  7. Szarpak L, Mierzejewska M, Jurek J, Kochanowska A, Gasecka A, Truszewski Z, et al. Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis. Biology (Basel). 2022;11(2):221. https://doi.org/10.3390/biology11020221
  8. Ganatra S, Hammond SP, Nohria A. The Novel Coronavirus Disease(COVID-19)ThreatforPatientsWithCardiovascular Disease and Cancer. JACC CardioOncol. 2020;2(2):350-355. https://doi.org/10.1016/j.jaccao.2020.03.001
  9. Netiazhenko VZ, Mostovyi SE, Safonova OM. [The Impact of COVID-19 upon Intracardiac Hemodynamics and Heart Rate Variability in Stable Coronary Artery Disease Patients]. Ukrainian Journal of Cardiovascular Surgery. 2023;31(1):19-28. Ukrainian. https://doi.org/10.30702/ujcvs/23.31(01)/NM009-1928
  10. Lushchyk UB, Novytskyi VV, Kolosova Yu O. [Current capabilities of capillaroscopy]. Kyiv: Istyna; 2004. Ukrainian.
  11. Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, et al.; EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19(3):102458. https://doi.org/10.1016/j.autrev.2020.102458
  12. Fullerton A, Stücker M, Wilhelm KP, Wårdell K, Anderson C, Fischer T, et al.; European Society of Contact Dermatitis Standardization Group. Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging. A report from the Standardization Group of the European Society of Contact Dermatitis based upon the HIRELADO European community project. Contact Dermatitis. 2002;46(3):129-140. https://doi.org/10.1034/j.1600-0536.2002.460301.x
  13. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, et al. Consensus on Microembolus Detection by TCD. International Consensus Group on Microembolus Detection. Stroke. 1998;29(3):725-729. https://doi.org/10.1161/01.str.29.3.725
  14. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452-458. https://doi.org/10.1038/bmt.2012.244
  15. Petrie A, Sabin C. Medical Statistics at a Glance. 4th ed. Hoboken (NJ): Wiley-Blackwell; 2020.
  16. Güven G. Microcirculatory alterations in critically ill patients and the effect of venous congestion on kidney function [Doctoral Thesis]. Rotterdam: Erasmus University; 2024. p. 281-287.
  17. Saha M, Dremin V, Rafailov I, Dunaev A, Sokolovski S, Rafailov E. Wearable Laser Doppler Flowmetry Sensor: A Feasibility Study with Smoker and Non-Smoker Volunteers. Biosensors (Basel). 2020;10(12):201. https://doi.org/10.3390/bios10120201
  18. Mondini L, Confalonieri P, Pozzan R, Ruggero L, Trotta L, Lerda S, et al. Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy. Diagnostics (Basel). 2023;13(11):1905. https://doi.org/10.3390/diagnostics13111905
  19. Sabioni L, De Lorenzo A, Castro-Faria-Neto HC, Estato V, Tibirica E. Long-term assessment of systemic microcirculatory function and plasma cytokines after coronavirus disease 2019 (COVID-19). Braz J Infect Dis. 2023;27(1):102719. https://doi.org/10.1016/j.bjid.2022.102719
  20. Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44(4):695-709. https://doi.org/10.1038/s41401-022-00998-0
  21. PassiR,BrittanM,BakerAH.Theroleoftheendotheliumin severeacuterespiratorysyndromecoronavirus2infection and pathogenesis. Curr Opin Physiol. 2023;34:100670. https://doi.org/10.1016/j.cophys.2023.100670
  22. Dharra R, Kumar Sharma A, Datta S. Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects Cytokine. 2023;169:156287. https://doi.org/10.1016/j.cyto.2023.156287
  23. Rabaan AA, Smajlović S, Tombuloglu H, Ćordić S, Hajdarević A, Kudić N, et al. SARS-CoV-2 infection and multi-organ system damage: A review. Biomol Biomed. 2023;23(1):37-52. https://doi.org/10.17305/bjbms.2022.7762
  24. Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21(8):2020-2031. https://doi.org/10.1016/j.jtha.2023.04.039
  25. Qureshi MA, Toori KU, Ahmed RM. Predictors of Mortality in COVID-19 patients: An observational study. Pak J Med Sci. 2023;39(1):241-247. https://doi.org/10.12669/pjms.39.1.6059
  26. Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, et al. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):663. https://doi.org/10.1186/s12879-021-06369-0
  27. MuhammadR,OguntiR,AhmadB,MunawarM,DonaldsonS, Sumon M, et al. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities. 2022;9(1):335-345. https://doi.org/10.1007/s40615-020-00961-x
  28. Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:E66. https://doi.org/10.5888/pcd18.210123
  29. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049-6057. https://doi.org/10.18632/aging.103000
  30. Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58(8):686-689. https://doi.org/10.1136/thorax.58.8.686
Published
2024-12-27
How to Cite
1.
Netiazhenko VZ, Mostovyi SE, Gurianov VG. Association of Microcirculation Parameters with Mortality in Patients with Coronary Artery Disease Combined with COVID-19. ujcvs [Internet]. 2024Dec.27 [cited 2025Jan.21];32(4):67-. Available from: https://cvs.org.ua/index.php/ujcvs/article/view/688
Issue
Ukrainian Journal of Cardiovascular Surgery Vol 32 No 4 2024
Section
ISCHEMIC HEART DISEASE